Last reviewed · How we verify

NCT03183414

Right Ventricular Dysfunction in Cardiac Surgery Patients

Completed Last updated 26 November 2019
What this trial tests

trial testing echocardiographic measurements in Right Ventricular Dysfunction in 15 participants. Completed in 30 June 2018.

Timeline
6 September 2017
Primary endpoint
20 June 2018
30 June 2018

Quick facts

Lead sponsorFrisius Medisch Centrum
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date6 September 2017
Primary completion20 June 2018
Estimated completion30 June 2018
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Frisius Medisch Centrum — full company profile →

Who can join

18 and older, any sex, with Right Ventricular Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To establish the correlation between echocardiographic parameters of the RV, measured with TEE and the right ventricular ejection fraction (thermodilution). To identify a time in the perioperative process when RV dysfunction occurs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Right Ventricular Dysfunction

Currently open trials in the same condition.

Other Frisius Medisch Centrum trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03183414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing